Mene Pangalos

Farxiga

Pharma

AZ's Farxiga looks set to gain a key 2nd nod in heart failure

AstraZeneca presented data that showed Farxiga can reduce the risk of death in heart failure patients regardless of their ejection fraction status.

Kevin Dunleavy Aug 29, 2022 8:08am

AstraZeneca

AZ's R&D chiefs talk roxadustat, Imfinzi-treme

Feb 10, 2022 10:13am